High blood pressure and obesity are two of the biggest health challenges facing the world today. Both conditions are extremely common and often occur together.
When a person carries excess body weight, the heart must work harder to pump blood around the body. Over time, this extra strain can raise blood pressure and increase the risk of heart attacks, strokes, heart failure, and kidney disease.
Doctors have long known that losing weight can help lower blood pressure. However, a new analysis suggests that modern weight-loss medications may provide even greater benefits than many people realize. Researchers found that the more weight people lost while taking these medications, the more their blood pressure tended to fall.
The research was presented at the European Congress on Obesity in Istanbul, Turkey, and was conducted by scientists from Leiden University Medical Center in the Netherlands and the University of Toronto in Canada.
The study focused on a new generation of obesity medications. These drugs include GLP-1 receptor agonists and newer medicines known as multi-hormone receptor modulators.
Some well-known medications in this category have become increasingly popular because they can help people lose substantial amounts of weight. Unlike older weight-loss treatments, these medicines work by affecting natural hormones involved in appetite, fullness, blood sugar control, and metabolism.
Scientists wanted to better understand how much of the blood pressure improvement seen with these medications was linked to weight loss itself. To investigate this question, they combined results from 32 large Phase III clinical trials involving 43,618 adults with overweight or obesity.
The participants had an average age of 54 years and an average body mass index of 35.5, which falls within the obesity range. Nearly 60 percent of participants had high blood pressure at the start of the studies. The trials lasted a median of 66 weeks, giving researchers a substantial amount of information to analyze.
Across all studies, participants taking the medications lost an average of 10.9 percent of their body weight compared with those taking placebo treatments. At the same time, their systolic blood pressure, the top number in a blood pressure reading, fell by an average of 5.2 millimeters of mercury.
When the researchers examined the relationship more closely, they discovered a clear pattern. For every 1 percent of body weight lost, systolic blood pressure dropped by about 0.34 millimeters of mercury. In other words, people who lost more weight generally experienced larger reductions in blood pressure.
The findings were remarkably consistent. Even after accounting for differences in age, body weight, sex, diabetes status, and study duration, the relationship between weight loss and blood pressure reduction remained strong.
Interestingly, the researchers also found evidence that these medications may lower blood pressure in ways that are not entirely related to weight loss. Scientists believe the drugs may directly affect blood vessels, improve how the kidneys handle salt, and reduce stress signals that contribute to elevated blood pressure. These additional effects may help explain why some people experience blood pressure improvements even before significant weight loss occurs.
The results are important because many people think of these medications mainly as weight-loss treatments. However, the study suggests they may also play a valuable role in improving cardiovascular health. Lower blood pressure can reduce the risk of heart disease, stroke, and other serious complications.
Despite the promising findings, the researchers caution that several limitations exist. The analysis combined information from entire clinical trials rather than individual patient data, making it difficult to determine exactly how and why the medications work in each person.
The studies also differed in their design, populations, and treatments, which may have influenced the results. In addition, blood pressure was not the primary outcome in most of the trials.
In reviewing the findings, this study provides strong evidence that modern obesity medications can offer meaningful blood pressure benefits alongside weight loss. The large number of participants and the consistency of the results strengthen confidence in the conclusions.
However, the study does not prove that the medications should replace traditional blood pressure treatments. Instead, it highlights an additional benefit that may help many people living with obesity and hypertension.
Future clinical trials will help clarify how much of the blood pressure improvement comes from weight loss itself and how much comes from the direct effects of the medications. If confirmed, these drugs could become an increasingly important tool for reducing both obesity and cardiovascular disease.
If you care about high blood pressure, please read studies about potatoes and high blood pressure, and top 10 choices for a blood pressure-friendly diet
For more information about high blood pressure, please see recent studies about impact of vitamins on high blood pressure you need to know, and the powerful link between high blood pressure and a potassium-rich diet.
Source: European Congress on Obesity.
